Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05397171
Title A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AstraZeneca
Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST